The present invention relates to the field of pharmaceutical containers and packages that allow a controlled dosage of liquid products, for example in individual drops or in a jet. More particularly, the invention relates to a tamper-proof dosing capillary cap or plug, which does not allow for reuse to be installed in the upper section of a container or package for liquid products. And a container that includes said insert or capillary cap, thus guaranteeing that the user does not fill and reuse said container.
In the field of containers and packages for liquid products, there has been a need to develop containers that allow evidence of the opening or handling of the container, which is known in the sector as tamper evident, to offer the final consumer the security that the container or the package has not been opened, and its content has not been altered.
A container is tamper-proof, when it makes it possible to easily identify or detect unauthorized access to protected content; in general, this is carried out through seals, marks, breakable rings or other techniques that show previous manipulation.
Another need for packages and containers is that they have a design that prevents them from being refilled after their first use or from being reused for another purpose. This mainly in the containers and packages of pharmaceutical and cosmetic products.
Therefore, it has been a constant objective in the container and packaging industry, especially within the pharmaceutical industry, to provide containers for liquid products that reveal undue manipulation and that, in turn, prevents the container from being refilled or reused of any kind.
The above because the reuse of packaging can cause a user to manage or use the altered content and cause an accident.
There are several types of containers on the market that prevent tampering or that evidence the tampering. For example, patent publication WO2009002717 presents a container with evidence of tampering. This publication does not refer to a dropper, but provides a closure system for a container in which the closure is non-removably attached to the neck of the container. The security system in this container consists of tabs not visible from the outside of the closure, in which a person would have to break those seals internally in order to uncouple the closure, which, in any case, is irreversible.
Furthermore, patent publication WO2013139352 presents a container with a dispensing closure. This publication shows that the container of the invention has a system in which, when attempting to release, rotate, or even unhook the dispenser closure of the container, a predetermined rupture link (or even the outer side wall) of the base, breaks at least partially. In other words, the dispenser closure breaks if it is improperly tampered.
Publication WO2016198967A1 discloses an improved dispensing system comprising a dosing unit that includes a skirt that has a projection or edge at its lower end and a container that includes a surface located on the inside of the shoulder of the container, where the surface retains the dosing unit through interference with said projection or edge of the dosing unit. Through these characteristics the reuse of the container is prevented.
However, there is still a need to develop technologies for containers that contain liquid products that not only have a system that allows evidence of their opening or handling, for the safety of the final consumer, but also includes a mechanism that prevents reusing the container, as a dropper.
It is an object of the present invention to provide an improved capillary insert that prevents reuse of the container as a dropper or multi-dose dispenser. Another object of the invention are containers of liquid products that incorporate the improved capillary insert. Yet another object of the invention is the use of the improved capillary insert in other inserts available in the state of the art.
The present invention consists of a capillary insert to administer liquid products, for example in the form of drops or a jet, which is installed in the neck of a reservoir or container for the liquid to be administered. The main characteristic of the capillary insert of the present invention is that it prevents its reuse and at the same time leaves evidence that it has been manipulated, violated, detached or damaged; and therefore, the insert is unusable since it disables the proper dosage of the product.
The capillary insert of the present invention prevents its reuse and tampering through one or more break zones located along the insert.
The present specification is complemented with a set of illustrative drawings of the preferred and never limiting examples of the invention.
The present invention provides an improved capillary insert that prevents reuse of the container as a dropper or multi-dose dispenser. The invention also relates to liquid product containers incorporating the improved capillary insert. Additionally, the invention provides the use of breaking zones in the capillary insert, in other commercially available inserts.
The present invention relates to a capillary insert (100) for administering liquid products, comprising: a cone (110) that extends axially in the opposite direction to form a skirt (120), where the cone (110) has in its part upper a hole (111) for the administration of liquids through an internal channel (112), the cone (110) has a frusto-conical configuration ending in a washer (114) that divides the cone (110) and the skirt (120), wherein the insert (100) has one or more homogeneous or non-homogeneous breaking zones, as shown in
The one or more breaking zones (130) of the capillary insert (100) are located in the cone (110) or in the skirt (120). Examples of these breaking zones (130) are shown in
In the capillary insert (100) of the invention the one or more thin (115) or thick (116) sections of thickness are visible or not visible. In one embodiment of the invention, the one or more thick sections of thickness (116) are located on the inner or external part of the breaking zone, as shown in
When said thin (115) or thick (116) sections of thickness are not visible, the invention refers to not being visible to the user as this depends on the insert manufacturing material, the size of the thick sections of thickness and the configuration of the thin (115) or thick (116) sections of thickness around the perimeter of the capillary insert (100).
Likewise,
The capillary insert (100) of the invention is made of resins from renewable and non-renewable sources.
Examples of resins from renewable sources used in the invention are selected from materials from commercially available renewable sources (e.g. ethanol), such as Bio-PE (Bio Polyethylene), Bio-PEAD/Bio-HDPE (High Density Bio Polyethylene), Bio-PEBD/Bio-LDPE (Low Density Bio Polyethylene), Bio-LLDPE (Linear Low Density Bio Polyethylene) and Bio-PP (Bio Polypropylene).
Examples of resins from non-renewable sources used in the invention are selected from polyolefins, including: Low-density polyethylene (PEBD or LDPE); high-density polyethylene (PEAD or HDPE); linear low density polyethylene (PELBD or LLDPE); polypropylene (PP); ethylene-propylene rubber (EPR); poly-alpha-olefin.
An embodiment of the invention corresponds to the use of the breaking zones (130) of the capillary insert (100) in any type of insert available on the market.
Another embodiment of the invention, as shown in
The present invention has industrial application in the packaging and container industry, particularly in the pharmaceutical industry, in that it provides an insert and a container for administration of medications or other liquid products in controlled amounts to a patient, preferably for the administration of drugs.
Other embodiments or embodiments of the present invention that are apparent to those skilled in the art from reading and practicing the present specification are understood to be included within the scope of protection of the present invention. The present specification is illustrative and not limiting of the scope of the invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2020/072921 | 8/14/2020 | WO |